Resumen
We undertook an individual patient data meta-analysis of the overall survival of 1216 patients with PSA-only recurrence of prostate cancer restaged with PSMA PET/CT before salvage treatment. Despite the patients having a low PSA at the recurrence, the restaging PSMA PET/CT markedly predicted the overall survival for the patients with a prescan PSA > 0.5 ng/mL.